Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Earns “Buy” Rating from HC Wainwright

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS)‘s stock had its “buy” rating restated by research analysts at HC Wainwright in a note issued to investors on Tuesday, Benzinga reports. They presently have a $14.00 target price on the stock. HC Wainwright‘s price target would indicate a potential upside of 42.86% from the company’s previous close.

SENS has been the subject of several other research reports. Mizuho cut their price objective on Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an “outperform” rating for the company in a research report on Wednesday, July 15th. Wall Street Zen upgraded Senseonics Holdings, Inc. Common Stock from a “strong sell” rating to a “sell” rating in a report on Saturday, August 8th. Barclays initiated coverage on Senseonics Holdings, Inc. Common Stock in a research note on Wednesday, October 7th. They issued an “equal weight” rating and a $10.00 target price for the company. Weiss Ratings raised Senseonics Holdings, Inc. Common Stock from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, November 4th. Finally, Raymond James Financial raised Senseonics Holdings, Inc. Common Stock from an “underperform” rating to a “market perform” rating in a report on Tuesday. Three research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $13.00.

Senseonics Holdings, Inc. Common Stock Stock Performance

NASDAQ SENS opened at $9.80 on Tuesday. Senseonics Holdings, Inc. Common Stock has a 1-year low of $4.79 and a 1-year high of $10.64. The company has a 50 day moving average of $9.12 and a 200-day moving average of $7.26. The company has a current ratio of 6.74, a quick ratio of 6.40 and a debt-to-equity ratio of 0.62. The firm has a market cap of $409.64 million, a price-to-earnings ratio of -4.39 and a beta of 1.04.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) last announced its earnings results on Monday, November 9th. The company reported ($0.50) EPS for the quarter, missing the consensus estimate of ($0.49) by ($0.01). The business had revenue of $19.56 million during the quarter. Senseonics Holdings, Inc. Common Stock had a negative return on equity of 165.80% and a negative net margin of 225.09%. On average, equities analysts forecast that Senseonics Holdings, Inc. Common Stock will post -2.31 earnings per share for the current fiscal year.

Insider Buying and Selling at Senseonics Holdings, Inc. Common Stock

In related news, Director Douglas Roeder acquired 13,953 shares of the company’s stock in a transaction that occurred on Wednesday, August 19th. The stock was purchased at an average price of $8.98 per share, for a total transaction of $125,297.94. Following the transaction, the director directly owned 171,191 shares of the company’s stock, valued at approximately $1,537,295.18. This trade represents a 8.87% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. 4.70% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Senseonics Holdings, Inc. Common Stock

Several hedge funds have recently added to or reduced their stakes in the company. Integrated Wealth Concepts LLC bought a new stake in Senseonics Holdings, Inc. Common Stock during the 2nd quarter worth about $36,000. The Manufacturers Life Insurance Company bought a new position in shares of Senseonics Holdings, Inc. Common Stock in the 2nd quarter valued at about $65,000. State of Wyoming acquired a new stake in shares of Senseonics Holdings, Inc. Common Stock during the 2nd quarter worth approximately $67,000. Kestra Advisory Services LLC acquired a new stake in shares of Senseonics Holdings, Inc. Common Stock during the 1st quarter worth approximately $68,000. Finally, Cetera Investment Advisers acquired a new stake in shares of Senseonics Holdings, Inc. Common Stock during the 1st quarter worth approximately $85,000. Institutional investors own 12.36% of the company’s stock.

About Senseonics Holdings, Inc. Common Stock

Senseonics Holdings, Inc is a medical technology company focused on developing and commercializing long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes. Its CGM technology is designed to measure glucose levels continuously through a small sensor inserted under the skin, with readings transmitted to an external smart transmitter and mobile application.

The company’s primary product is the Eversense CGM system. Unlike many conventional CGM systems that use an externally worn sensor, Eversense uses an implantable sensor and a removable, rechargeable transmitter worn over the sensor site.